What these buzzy new tests can and can't tell you.

GRAIL, Inc. GRAL announced the submission of the final module of its premarket approval application to the FDA for the ...

Add Yahoo as a preferred source to see more of our stories on Google. "No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat ...

A ground-breaking blood test can pick up cancer cases among patients who have been falsely reassured they do not have the disease, research has suggested. The Galleri test — dubbed the 'holy grail' ...

Pancreatic cancer is the third leading cause of cancer-related deaths, trailing behind lung cancer and colorectal cancer, a ...

GRAIL moves from scientific vision to proven clinical reality, as PATHFINDER 2 confirms that multi-cancer early detection works effectively at scale. Physician and patient adoption is accelerating, ...

By: Gretchen Stipec, M.D., radiologist, Cancer Institute, Long Beach Medical Center Seniors account for nearly 28% of all new cancer cases and face higher mortality rates than younger individuals. To ...

GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced the submission of the final module of the Premarket Approval (PMA) ...

"No cancer signal detected." The blood test results popped up in my online health portal without much fanfare. A doctor would chat about them with me later, congratulating me on the "phew"-worthy ...